Detalhe da pesquisa
1.
Brodalumab in plaque psoriasis: Real-world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks.
J Eur Acad Dermatol Venereol
; 37(4): 689-697, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36562663
2.
Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology-Rheumatology clinic: a retrospective real-world study.
Rheumatol Int
; 42(6): 1035-1041, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35435445
3.
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis.
J Eur Acad Dermatol Venereol
; 2024 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38506605
4.
Bimekizumab in psoriasis: a monocentric study evaluating short- and mid-term effectiveness and safety profile in a real-world setting.
Arch Dermatol Res
; 316(5): 133, 2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38662223
5.
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study.
Am J Clin Dermatol
; 25(2): 333-342, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38265746
6.
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review.
Biomedicines
; 11(2)2023 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36830855
7.
Case Report: Malignant melanoma in a patient with Crohn's disease treated with ustekinumab.
F1000Res
; 11: 424, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-37867623
8.
Drug Survival of Interleukin (IL)17 and IL23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multicountry, Multicentric Cohort Study.
Am J Clin Dermatol
; 23(6): 891-904, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35976568
9.
The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway.
Proc Natl Acad Sci U S A
; 105(44): 17091-6, 2008 Nov 04.
Artigo
Inglês
| MEDLINE | ID: mdl-18957551
10.
Systemic lupus erythematosus following rituximab treatment for non-Hodgkin lymphoma.
J Dtsch Dermatol Ges
; 14(3): 298-301, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26788717
11.
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy.
Dermatology
; 218(2): 146-50, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-18971577
12.
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
J Am Acad Dermatol
; 57(2): 269-75, 2007 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-17574299
13.
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study.
Mol Diagn Ther
; 21(3): 295-301, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28130758
14.
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes.
Oncogene
; 24(46): 6970-5, 2005 Oct 20.
Artigo
Inglês
| MEDLINE | ID: mdl-16007154
15.
The p73 gene is an anti-tumoral target of the RARbeta/gamma-selective retinoid tazarotene.
J Invest Dermatol
; 123(6): 1162-8, 2004 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-15610529
16.
Treatment of psoriasis and psoriatic arthritis.
BioDrugs
; 27 Suppl 1: 3-12, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23990277
17.
Infliximab in psoriasis and psoriatic arthritis.
BioDrugs
; 27 Suppl 1: 13-23, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23990278
18.
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab.
Clin Cosmet Investig Dermatol
; 2: 95-103, 2009 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-21436972
19.
IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasias.
J Invest Dermatol
; 129(1): 60-9, 2009 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-18633439
20.
Long-term efficacy of adalimumab in generalized pustular psoriasis.
J Dermatolog Treat
; 19(3): 185-7, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18569276